Skip to main content

OPHI · CollPlant Biotechnologies Ltd

Track OPHI — free
$3.65 At close · Nov 13
Market Cap
$11.23M
Shares
3.08M
Volume · Nov 13 387.75K Avg daily vol (1 sessions) 387.75K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.65 Open$4.10 Day$3.60–4.28 Available close range$3.65–3.65 Avg vol available · 1d388K Short int6 · 0.0% of shares Short vol71% Last earningsSep 30, 2024 DataNov 2026–Nov 2026

The closing range uses available history since Nov 13, 2026; less than a full year is stored.

Up next

Latest documents

2026
Nov 12
Current report 6-K
Shares Begin Trading on Nasdaq Under OPHI

CollPlant Biotechnologies Ltd. said its ordinary shares will begin trading on Nasdaq as “OPHI” at the open on November 13, 2026, after closing under “CLGN” on November 12, 2026; no shareholder action is required.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) (“CollPlant”) today announced that its ordinary shares will begin trading on Nasdaq under the new ticker symbol “OPHI,” effective at the open of trading on November 13, 2026. The shares will continue to trade under “CLGN” through the close of trading on November 12, 2026. No action is required by shareholders in connection with the ticker symbol change. Open the document at this passage
Nov 12
Current report 6-K
LightSolver to debut all-optical computer at SC26

CollPlant Biotechnologies Ltd. subsidiary LightSolver will publicly demonstrate its all-optical Laser Processing Unit at SC26 in Chicago November 16-19, 2026, solving linear equations, differential equations and complex optimization problems, alongside Boeing corrosion-simulation benchmarks.

3 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. (“LightSolver”), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, will unveil the LPU capabilities in a first public demonstration at SC26, the International Conference for High Performance Computing, taking place November 15-20, 2026 in Chicago. The demonstration will be presented at LightSolver’s booth #5102 during the exhibition, November 16-19. In this first public demonstration of an all-optical computer, LightSolver will showcase live how the LPU solves real mathematical and computational problems – including systems of linear equations, differential equations, and complex optimization problems – using only interacting light. LightSolver will present its work with Boeing on PDE-based corrosion simulation at the SC26 Exhibitor Forum. Open the document at this passage
Nov 5
Current report 6-K
IIA Approves Grant for LightSolver LPU Development

CollPlant Biotechnologies Ltd. said the Israel Innovation Authority approved an approximately $1.8 million grant for subsidiary LightSolver Ltd. to advance its Laser Processing Unit (LPU) development; receipt remains subject to the authority’s customary terms.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that the Israel Innovation Authority (IIA) has approved a grant of approximately $1.8 million to its subsidiary, LightSolver Ltd. (“LightSolver”), to support the continued development of its Laser Processing Unit (LPU), an all-optical, laser-based computing platform. The grant is subject to the IIA’s customary terms. Open the document at this passage
Nov 4
Current report 6-K
Proposed Rebrand Reflects Expansion Into Computing With Light

CollPlant Biotechnologies Ltd. proposed changing its name to OptiPhi Computing Ltd. and Nasdaq ticker from “CLGN” to “OPHI,” reflecting expansion into photonic computing after acquiring LightSolver Ltd. in September 2026; shareholder approval is required.

2 source passages
CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company’s name to OptiPhi Computing Ltd., subject to shareholders approval and completion of the applicable corporate and regulatory procedures. The proposed name reflects the Company’s focus on computing with light following its acquisition of LightSolver Ltd. (“LightSolver”) in September 2026. In connection with the proposed change, the Company also intends to change its Nasdaq trading symbol from “CLGN” to “OPHI”, subject to Nasdaq confirmation and completion of the applicable process. Open the document at this passage
All documents

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Limited Momentum Limited Sentiment Bearish Fundamentals Excellent Quant / Vol Limited
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Limited
Not enough data for a confident read.
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
14 of 15 funds reported for Sep 30 · net -1.3M sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
15 holders — mid 3-yr range
Fundamentals
Excellent
Revenue growth +360%
Y/Y
Gross margin 65%
expanding
EPS growth +35%
Y/Y
Free cash flow $-9.4M
Balance sheet $5.6M
net cash
Quant / Vol
risk profile
Limited
Not enough data for a confident read.

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
0 · 1 · 0
50 / 200-day cross
No cross Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
14 of 15 funds reported for Sep 30 · net -1.3M sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
15 holders — mid 3-yr range
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OPHI
CollPlant Biotechnologies Ltd
this stock
$11.23M — +360.4% — 0.0%
VRTX
Vertex Pharmaceuticals Inc
$136.56B +18.8% +46.2% 34.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
$98.84B +23.8% +20.8% 21.1 2.1%
MRNA
Moderna, Inc.
$90.38B +657.4% +4.3% — 8.2%
CSLLY
Csl Ltd
$66.05B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
10
% held
11.5%
Reported
14 of 15
Top holder
BROWN ADVISORY INC
Held Float
View
Short & Settlement
Short Interest
Shares short
6
Days to cover
1000.0d
Change
0 sh
View
Short Volume
Short vol %
71%
As of
Nov 13, 2026
Short Total
View
Financials
Financials
Revenue (FY)
$2.4M
Net income (FY)
$-11.5M
EPS diluted
$-0.94
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 12, 2026
This year
38

CollPlant Biotechnologies Ltd. said its ordinary shares will begin trading on Nasdaq as “OPHI” at the open on November 13, 2026, after closing under “CLGN” on November 12, 2026; no shareholder action is required.

View
Proposed Sales
Value
$58.9K
Shares
15.6K
Filed
Oct 27, 2026
View
Exempt Offerings
Offering
$9.2M
Filed
Oct 22, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 30, 2024
View
Investor Relations
Latest news
LightSolver Secures ~$1.8 Million…
Published
Nov 5, 2026
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
OPHI — — — — —
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY — — — — —
Key facts CIK 1631487 13F (30d) 7 filings 7 filers Visit website Investor relations